PharmaSGP Holding SE Logo

PharmaSGP Holding SE

ISIN: DE000A2P4LJ5 | Ticker: PSG | LEI: 3912005CZ12PVVCIPT91
Sector: Health Care – Sub-Industry: Pharmaceuticals
Country: Germany
Website Investor Relations

About PharmaSGP Holding SE

Company Description

harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.

Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.

In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.

Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.

Year founded

2019

Served area

Worldwide

Headcount

66

Headquarters

Lochhamer Schlag 21, 82166 Gräfelfing – Germany

Filings & Publications

2021
2020
2022

2021

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG / GER
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
05.10.22 MMI Leisure & Capital Management GmbH Close relation Buy EUR 125,383.20
05.10.22 Hillen, Ingo Board Buy EUR 1,048.00
05.10.22 MMI Leisure & Capital Management GmbH Close relation Buy EUR 26.60
30.05.22 Wittig, Dr. Thomas Supervisory board Buy EUR 138,953.80
30.05.22 Schröter, Jasmin Close relation Buy EUR 119,660.00
30.05.22 Simon-Schröter, Dr. Wolfram Other Buy EUR 10,040.00
25.04.22 FUTRUE GmbH Close relation Buy EUR 208,180.53
25.04.22 MMI Leisure & Capital Management GmbH Close relation Sell EUR 197,193.60
25.04.22 Bloching, Prof. Dr. Micha Supervisory board Sell EUR 171,825.00
25.04.22 MMI Leisure & Capital Management GmbH Close relation Sell EUR 99.00

Capital markets information

ISIN

DE000A2P4LJ5

LEI

3912005CZ12PVVCIPT91

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Designated Sponsor

Joh. Berenberg, Gossler & Co. KG

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.